logo-loader
viewAdvanced Oncotherapy PLC

Advanced Oncotherapy secures £18.4mln of additional funding

A total of £14.4mln has come via investors, who paid 40p a share for new stock, which was at a premium to last night’s close. It has also agreed a loan facility with Nerano Pharma

Advanced Oncotherapy PLC -
Proton therapy facilities have traditionally been pricey and large, requiring a space the size of a football pitch to run. But AVO thinks it has solved that problem, and LIGHT is being built to fit in the basement of the Harley Street townhouse

Advanced Oncotherapy PLC (LON:AVO) said it has secured £18.4mln of additional funding as it heads into the fit-out stage for its state-of–the-art proton beam therapy centre on London’s Harley Street.

A total of £14.4mln has come via investors, who paid 40p a share for new stock, which was at a premium to last night’s close. It has also agreed a loan facility with Nerano Pharma.

An update last month revealed the company was making good progress with hardware elements for its LIGHT System and is on track to treat its first cancer patient next year.

"With most hardware components already manufactured and in the process of being delivered at our integration site, I am delighted that we have been able to complete this significant fund raising, which will allow us to focus our resources on progressing the verification and validation needed to ensure first patient treatment by the end of 2020,” said chief executive Nicolas Serandour.

AVO’s LIGHT technology is based on work by ADAM, which AVO bought in 2013 from CERN – the world’s largest particle physics lab that built the Hadron collider.

The major plus point of proton therapy for cancer is that it can pinpoint tumours more precisely than traditional radiation treatment, which means less damage to surrounding healthy tissues.

Proton therapy facilities have traditionally been pricey and large, requiring a space the size of a football pitch to run.

But AVO thinks it has solved that problem, and LIGHT is being built to fit in the basement of the Harley Street townhouse.

Work is currently being carried out on the hardware at the firm’s other site at Daresbury in Cheshire.

So, component parts such as side-coupled drift tube linacs and coupled-cavity linacs are due for delivery there between now and the early fourth-quarter. Linacs are linear accelerators, which force particles to travel in straight lines.

At the same time, the treatment room is being prepared to receive the proton beam kit, while advanced software is being developed that will ensure the optimal performance of the technology.

Quick facts: Advanced Oncotherapy PLC

Price: 37.5 GBX

LSE:AVO
Market: LSE
Market Cap: £91.44 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Advanced Oncotherapy PLC named herein, including the promotion by the Company of Advanced Oncotherapy PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: VR Education's ENGAGE platform to be included in new 5G VR...

Headlines from the Proactive UK newsroom. VR Education’s (LON:VRE) Engage platform has been chosen as an embedded title in a new 5G virtual reality headset being developed by a consortium of Deutsche Telekom, Qualcomm and XRSPACE. The new headset is due to launch in...

1 week, 3 days ago

RNS

Holding(s) in Company

1 week, 4 days ago

Total Voting Rights

2 weeks, 1 day ago

Holding(s) in Company

2 weeks, 2 days ago

Total Voting Rights

on 6/11/19

Change of Broker

on 10/10/19

Total Voting Rights

on 30/9/19

2 min read